Open-Label Extension of EryDex Study IEDAT-04-2022
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Dirk Thye, MD
Quince Therapeutics S.p.A.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
21 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Copenhagen University Hospital, Rigshospitalet, Department of Pediatric Neurology
Copenhagen, Denmark, Denmark
- University Hospital Frankfurt, Pediatric and Adolescent Clinic
Frankfurt, Germany, Germany
- Ikf Pneumologie Gmbh & Co. Kg; Institut Für Klinische Forschung Pneumologie Clinical Research Center Respiratory Diseases
Frankfurt am Main, Hesse, Germany
- Spedali Civili Di Brescia, Pediatric Immunology Department
Brescia, Italy, Italy
- Policlinico Umberto I, la Sapienza University, Department of Neurosciences and Menthal Health
Roma, Italy, Italy
- Oslo University Hospital, Rikshospitalet, Division of Pediatric and Adolescent Medicine, Norwegian National Unit for Newborn Screening
Oslo, Norway, Norway
- Medpolonia Sp Zoo
Poznan, Poland
- Instytut "pomnik-Centrum Zdrowia Dziecka", Immunology Clinic
Warsaw, Poland
- Hospital Universitari Vall D'Hebron, Department of Pediatric Neurology
Barcelona, Spain, Spain
- Hospital Universitario la Paz, Department of Pediatric Neurology
Madrid, Spain, Spain
- Universitary Hospital Virgen del Rocío
Seville, Spain
- University Children'S Hospital Zürich - Eleonore Foundation
Zurich, Switzerland
- Great Ormond Street Hospital for Children, Zayed Centre for Research
London, United Kingdom, United Kingdom
- Nottingham Children'S Hospital, Queen'S Medical Center, Children'S Neurology
Nottingham, United Kingdom, United Kingdom
- University Hospitals Birmingham Nhs Foundation Trust
Birmingham, United Kingdom
- St George'S University Hospitals Nhs Foundation Trust, Centre for Neonatal and Paediatric Infection
London, United Kingdom
- University of California Los Angeles (ucla), Ataxia Center and Hd Center of Excellence
Los Angeles, California, United States
- the Johns Hopkins Hospital, Division of Pediatric Allergy and Immunology
Baltimore, Maryland, United States
- Saint Peter'S University Hospital, Inc.
New Brunswick, New Jersey, United States
- Cincinnati Children'S Hospital, Division of Neurology
Cincinnati, Ohio, United States
- Ut Health Houston, Department of Pediatrics, Division of Child & Adolescent Neurology
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 11 Dec 2024
- Primary completion
- 30 Jan 2026
- Completion
- 30 Jan 2026
- Last update posted
- 5 May 2026
- Registered enrollment
- 101
- Registry id
- NCT06664853
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.